Scinai Immunotherapeutics Ltd. (TLV:BVXV)

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had revenue of $386.50K USD in the quarter ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to $1.15M, up 303.87% year-over-year. In the year 2024, Scinai Immunotherapeutics had annual revenue of $658.00K.

• Revenue (ttm): $1.15M
• Revenue Growth: +303.87%
• P/S Ratio: 1.90
• Revenue / Employee: $37.00K
• Employees: 31
• Market Cap: 7.35M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	658.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-